Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Cancer Genomics and Diagnostics, and Genetic Associations and Epidemiology.
Colchicine and Longitudinal Dynamics of Clonal Hematopoiesis
Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6976 women
Clonal Hematopoiesis of Indeterminate Potential and Progression of CKD
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy
Clonal Hematopoiesis and Cardiovascular Outcomes in Older Women
Clonal Hematopoiesis and Risk of New-Onset Myocarditis and Pericarditis
Association of Clonal Hematopoiesis of Indeterminate Potential with Cardiovascular Events in Patients with CKD
Epigenome-wide DNA methylation association study of CHIP provides insight into perturbed gene regulation
Clonal Hematopoiesis and Incident Heart Failure
Genetics and context for precision health in Greater Boston
Human plasma proteomic profile of clonal hematopoiesis
<i>JAK2</i>-mutant clonal hematopoiesis is associated with venous thromboembolism
Clonal Hematopoiesis Risk Score and All-Cause and Cardiovascular Mortality in Older Adults
Atrial Fibrillation and Clonal Hematopoiesis in <i>TET2</i> and <i>ASXL1</i>
Long-term longitudinal analysis of 4,187 participants reveals insights into determinants of clonal hematopoiesis
Clonal hematopoiesis of indeterminate potential is associated with reduced risk of cognitive impairment in patients with chronic kidney disease
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial
Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis
Clonal haematopoiesis and risk of chronic liver disease
A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic datasets
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease
Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis
Genetic modification of inflammation- and clonal hematopoiesis–associated cardiovascular risk
Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias
Age at Menopause, Leukocyte Telomere Length, and Coronary Artery Disease in Postmenopausal Women
Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
Clonal Hematopoiesis and Venous Thromboembolism in the UK Biobank
Author Correction: Clonal haematopoiesis and risk of chronic liver disease
<i>TET2</i>-mutant clonal hematopoiesis and risk of gout